We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

193 hedge funds and large institutions have $1.21B invested in Viking Therapeutics in 2023 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $95.3M | Put options by funds: $47.3M

30% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 50

21% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 42

10% more capital invested

Capital invested by funds: $1.11B → $1.21B (+$105M)

5% more funds holding

Funds holding: 184 → 193 (+9)

9.84% less ownership

Funds ownership: 84.75% → 74.91% (-9.8%)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
193
Holders Change
+9
Holders Change %
+4.89%
% of All Funds
3.03%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
51
Increased
65
Reduced
50
Closed
42
Calls
$95.3M
Puts
$47.3M
Net Calls
+$48M
Net Calls Change
-$10.3M

Top Buyers

1
BlackRock
BlackRock
New York
+$102M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$84.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$61.8M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$33.3M
5
American Century Companies
American Century Companies
Missouri
+$28.4M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$42.2M
2
LCM
Laurion Capital Management
New York
-$32.4M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$26.1M
4
CAM
Cormorant Asset Management
Massachusetts
-$17.5M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$243M +$84.9M +4,053,059 +37%
BlackRock
2
BlackRock
New York
$112M +$102M +4,854,645 +238%
Vanguard Group
3
Vanguard Group
Pennsylvania
$82.9M +$22.1M +1,053,718 +26%
State Street
4
State Street
Massachusetts
$78.1M -$9.67M -461,568 -9%
Viking Global Investors
5
Viking Global Investors
Connecticut
$57.5M +$33.3M +1,589,443 +81%
AllianceBernstein
6
AllianceBernstein
Tennessee
$48M +$61.8M +2,947,905 +21,587%
BC
7
Boxer Capital
California
$32.4M – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$29.9M +$20.6M +983,207 +114%
Millennium Management
9
Millennium Management
New York
$29.6M -$42.2M -2,014,876 -52%
WA
10
Wasatch Advisors
Utah
$27.7M +$84.5K +4,031 +0.2%
American Century Companies
11
American Century Companies
Missouri
$22.4M +$28.4M +1,355,183 +5,445%
Morgan Stanley
12
Morgan Stanley
New York
$21.4M +$9.27M +442,366 +50%
DM
13
Deerfield Management
New York
$18.2M – – –
RI
14
RTW Investments
New York
$16.2M – – –
Northern Trust
15
Northern Trust
Illinois
$14.8M +$15.5M +739,868 +431%
Invesco
16
Invesco
Georgia
$13.4M +$17.3M +825,894 New
Victory Capital Management
17
Victory Capital Management
Texas
$13.3M +$11.6M +553,792 +209%
EAM
18
Eventide Asset Management
Massachusetts
$12.2M +$15.7M +750,000 New
IHAM
19
Integral Health Asset Management
New York
$11.8M +$60.8K +2,900 +0.4%
Goldman Sachs
20
Goldman Sachs
New York
$11.2M +$400K +19,076 +3%
GTC
21
Ghost Tree Capital
New York
$10.5M +$1.05M +50,000 +8%
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$9.97M +$1.23M +58,661 +11%
GPP
23
Great Point Partners
Connecticut
$9.7M -$8.41M -401,450 -40%
5VM
24
5AM Venture Management
California
$9.48M +$4.92M +235,000 +67%
6CM
25
683 Capital Management
New York
$9.4M – – –
1
2 3 4 5

VKTX Hedge Fund Activity: Q2 2023 in Review

193 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q2 2023, worth a combined $1.21B — up 9.5% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new VKTX positions and 42 closed out — a net gain of 9 holders — while 65 added to existing stakes and 50 trimmed.

The largest buyer was BlackRock, adding an estimated $102M. The largest seller was Millennium Management, cutting an estimated $42.2M.

  • 193 institutional investors held Viking Therapeutics (VKTX) as of Q2 2023, up from 184 in Q1 2023.
  • Funds reported $1.21B of Viking Therapeutics stock for Q2 2023, up 9.5% quarter-over-quarter.
  • 51 funds opened new Viking Therapeutics positions in Q2 2023 and 42 closed out, a net change of +9 holders.
  • The largest Viking Therapeutics buyer in Q2 2023 was BlackRock, an estimated $102M added.
  • The largest Viking Therapeutics seller in Q2 2023 was Millennium Management, an estimated $42.2M sold.

Based on aggregated 13F filings for Q2 2023.